Statins Reduce Bladder Cancer Progression Risk
They studied 4,834 patients who had superficial bladder cancer and transurethral resection of tumor procedure. Of the 4,834 patients, 1,211 (25%) were statin users.
Statin use did not affect cancer recurrence, but it was associated with a 42% decreased risk of progression to cystectomy for muscle-invasive disease and a 46% decrease in death risk from any cause.
Findings were reported here at the 2008 Genitourinary Cancers Symposium.